Laniohan, Joselito B.

HRN: 27-46-89  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/16/2025
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
07/16/2025
07/22/2025
IV
4.5gm
Q8
Cellulitis
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines